Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Healthcare Biotechnology
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

Soligenix Announces Positive Preliminary Nonclinical Results in Macrophage Activation Syndrome

PR Newswire January 5, 2015

RestorGenex Announces Issuance of European Patent for its Dermatology Program

Business Wire January 5, 2015

BioLife Solutions Biopreservation Media Products Embedded in 175 Cellular Immunotherapy & Other Regenerative Medicine Clinical Trials

PR Newswire January 5, 2015

Professor Martti Uusitupa receives Pohjola and Suomi Mutual Medical Award

Thomson Reuters ONE January 5, 2015

Bad luck plays a big role in getting cancer, study says

UPI January 3, 2015

Biotech Showcase(TM) 2015 Kicks off in One Week

Business Wire January 2, 2015

Home Audio Systems, The Growth of Wireless Audio: Wireless Headphones, Mobile Speakers, Room Speakers, Multi-room Speakers, Sound Bars and HTiB Systems

PR Newswire January 2, 2015

Researchers find protein capable of editing other proteins

UPI January 2, 2015

The Global Prenatal and Newborn Genetic Testing Market Will Grow at a CAGR of More Than 31 Percent from 2015 to 2019: TechNavio

Business Wire January 2, 2015

Aurora Diagnostics Announces Promotion of Bruce Walton to Chief Operating Officer

Business Wire January 2, 2015

Conversion Right Triggered for LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021

Business Wire January 2, 2015

Aethlon Medical Announces Approval of Ebola Treatment Protocol

PR Newswire January 2, 2015

Cesca Receives Feedback From the FDA on Its Pivotal Investigational Device Exemption ("IDE") Application for Treating Critical Limb Ischemia ("CLI")

GlobeNewswire January 2, 2015

PT Rimba Raya Conservation Hands Over Village Development Funds to Village Chiefs in Central Kalimantan

ACN Newswire January 2, 2015

MD Buyline Releases Q4.2014 "User Satisfaction Trending(TM)" Data

Business Wire January 1, 2015

Tekmira Provides Update on TKM-PLK1 Phase I/II Clinical Study in Patients With Advanced Gastrointestinal Neuroendocrine Tumors and Adrenocortical Carcinoma

GlobeNewswire December 31, 2014

Plandai Biotechnology, Inc. Provides Year-End Shareholder Update

Marketwired December 31, 2014

Tute Genomics Introduces Andrew Olson as New VP of Sales

PR Newswire December 31, 2014

Cell Wholesale Inc. New Hires Increase Total Work Force Resulting from Major Expansion Plans

Business Wire December 30, 2014

On the Deficient Current Flu Vaccine:

PR Newswire December 30, 2014